Niagen Bioscience Forecast, price target & analysts
Niagen Bioscience Target price 2026 - Analyst rating & recommendation
Niagen Bioscience Classifications & Recommendation
Niagen Bioscience Price Target
| Target Price | $10.71 |
| Price | $2.99 |
| Potential |
258.19%
register free of charge
|
| Number of Estimates | 8 |
|
8 Analysts have issued a price target Niagen Bioscience 2027 .
The average Niagen Bioscience target price is $10.71.
This is
258.19%
register free of charge
$23.10
672.58%
register free of charge
$8.59
187.12%
register free of charge
|
|
| A rating was issued by 12 analysts: 11 Analysts recommend Niagen Bioscience to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Niagen Bioscience stock has an average upside potential 2027 of
258.19%
register free of charge
|
Sales and Margin forecast 2026, 2027 & 2028
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Million $ | 129.42 | 135.78 |
| 29.94% | 4.91% | |
| EBITDA Margin | 11.65% | 10.33% |
| 35.89% | 11.35% | |
| Net Margin | 13.43% | 7.94% |
| 56.44% | 40.87% |
8 Analysts have issued a sales forecast Niagen Bioscience 2026 . The average Niagen Bioscience sales estimate is
This results in the following potential growth metrics:
6 Analysts have issued an Niagen Bioscience EBITDA forecast 2026. The average Niagen Bioscience EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
8 Niagen Bioscience Analysts have issued a net profit forecast 2026. The average Niagen Bioscience net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 & 2028
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share $ | 0.20 | 0.14 |
| 81.82% | 30.00% | |
| P/E | 21.88 | |
| EV/Sales | 1.25 |
8 Analysts have issued a Niagen Bioscience forecast for earnings per share. The average Niagen Bioscience EPS is
This results in the following potential growth metrics and future valuations:
Niagen Bioscience...
Current Niagen Bioscience Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | May 11 2026 |
| Canaccord Genuity |
Locked
➜
Locked
|
Locked | May 05 2026 |
| Canaccord Genuity |
Locked
➜
Locked
|
Locked | Mar 31 2026 |
| Canaccord Genuity |
Locked
➜
Locked
|
Locked | Mar 05 2026 |
| Canaccord Genuity |
Locked
➜
Locked
|
Locked | Nov 05 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Aug 11 2025 |
| Canaccord Genuity |
Locked
➜
Locked
|
Locked | Jun 10 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
May 11 2026 |
|
Locked
Canaccord Genuity:
Locked
➜
Locked
|
May 05 2026 |
|
Locked
Canaccord Genuity:
Locked
➜
Locked
|
Mar 31 2026 |
|
Locked
Canaccord Genuity:
Locked
➜
Locked
|
Mar 05 2026 |
|
Locked
Canaccord Genuity:
Locked
➜
Locked
|
Nov 05 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Aug 11 2025 |
|
Locked
Canaccord Genuity:
Locked
➜
Locked
|
Jun 10 2025 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
